Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-18 Sale |
2025-02-20 5:11 pm |
Neumora Therapeutics Inc. | NMRA | Pinto Joshua President |
8,048 | $1.6746 | $13,477 | 215,917 (Indirect Direct) |
View |
| 2024-08-27 Sale |
2024-08-27 5:58 pm |
Neumora Therapeutics Inc. | NMRA | Pinto Joshua Chief Financial Officer |
15,693 | $11.39 | $178,806 | 223,965 (Indirect Direct) |
View |
| 2024-08-22 Sale |
2024-08-26 6:17 pm |
Neumora Therapeutics Inc. | NMRA | Pinto Joshua Chief Financial Officer |
84,307 | $11.67 | $984,061 | 239,658 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-13 Option Award |
2025-02-18 4:30 pm |
N/A 2035-02-13 |
Neumora Therapeutics Inc. | NMRA | Pinto Joshua President |
4,734,428 | $0 | 4,734,428 (Direct) |
View |
Ownership |
2025-01-30 9:28 pm |
N/A 2034-09-26 |
Metsera Inc. | MTSR | Pinto Joshua Director |
0 | $0 | 148,953 (Direct) |
View |
| 2024-04-17 Gift |
2024-06-28 9:00 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Pinto Joshua Chief Financial Officer |
238,965 | $0 | 323,965 (Indirect) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:21 pm |
N/A 2034-02-13 |
Neumora Therapeutics Inc. | NMRA | Pinto Joshua Chief Financial Officer |
255,000 | $0 | 493,965 (Direct) |
View |
Ownership |
2023-09-14 6:52 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Pinto Joshua Chief Financial Officer |
0 | $0 | 1,803,393 (Direct) |
View |